Austin—Favor, the startup with a mobile app that offers to deliver anything, is closing all of its operations outside of Texas, including in cities such as Boston and Denver.
The move to work only in Texas, where Austin, TX-based Favor... Read more »
Biogen is paying Danish firm Forward Pharma $1.25 billion to settle a patent infringement lawsuit filed over the company’s multiple sclerosis pill dimethyl fumarate (Tecfidera).
The settlement announced Tuesday with Forward (NASDAQ: FWP) could also put Cambridge, MA-based Biogen (NASDAQ:... Read more »
Let’s catch up with the latest innovation news from Texas.
—Initially set up as a crowdfunding-type platform for small to medium oil and gas operators, EnergyFunders has now expanded its services beyond providing cash. The site, which launched in 2015,... Read more »
Artificial intelligence software firm Neurala cut its teeth developing technology for government entities, including working on advanced navigation software for NASA’s planetary exploration robots.
Now, as A.I. technologies move further into our daily lives, 11-year-old Neurala says it is starting to... Read more »
This was a busy week. Let’s get right to our review featuring a Microsoft acquisition in “machine literacy”; Amazon’s plans to hire 100,000 full-time U.S. workers by mid-2018; a green light for the UW’s new computer science building; transparency from Microsoft... Read more »
The Montreal-based startup Microsoft is acquiring aims to teach machines to read so they can get smarter on their own.
The acquisition of Maluuba, a five-year-old startup, adds a trove of deep learning researchers to Microsoft’s already world-class artificial intelligence research... Read more »
Houston—EnergyFunders started out as a website to connect smaller oil and gas operators to interested investors. Turns out, the need wasn’t only in the matchmaking but in playing therapist throughout the relationship of a drilling project.
“The project is a... Read more »
[Corrected, 1/14/16, see below] This past week, the biopharma industry made its annual January pilgrimage to San Francisco for the J.P. Morgan Healthcare Conference. 2016 was a whirlwind year in biotech, and the biopharma gods rewarded attendees with a... Read more »